ImmuPharma (25I) Financial Statements
ImmuPharma Financial Overview
ImmuPharma's market cap is currently $24.30M. The company's EPS TTM is $-0.01; its P/E ratio is -2.60; ImmuPharma has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 118.35K |
| Gross Profit | $ -35.30K | $ -63.88K | $ -37.61K | $ -118.00K | $ 118.35K |
| Operating Income | $ -2.54M | $ -2.68M | $ -3.06M | $ -3.03M | $ -6.59M |
| EBITDA | $ -2.51M | $ -2.61M | $ -3.02M | $ -2.91M | $ -8.70M |
| Net Income | $ -1.81M | $ -2.48M | $ -2.92M | $ -3.81M | $ -8.17M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.35M | $ 236.90K | $ 208.48K | $ 667.81K | $ 1.65M |
| Total Assets | $ 1.88M | $ 977.01K | $ 2.72M | $ 3.97M | $ 6.00M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 111.00 | $ 700.00 |
| Net Debt | $ -1.35M | $ -236.90K | $ -208.48K | $ -667.70K | $ -1.65M |
| Total Liabilities | $ 1.19M | $ 1.52M | $ 1.67M | $ 1.45M | $ 1.58M |
| Stockholders' Equity | $ 686.86K | $ -542.86K | $ 1.06M | $ 2.52M | $ 4.41M |
| Cash Flow | |||||
| Free Cash Flow | $ -2.37M | $ -1.77M | $ -1.36M | $ -2.45M | $ -4.88M |
| Operating Cash Flow | $ -2.37M | $ -1.77M | $ -1.36M | $ -2.35M | $ -4.83M |
| Investing Cash Flow | $ 6.91K | $ 1.29M | $ 188.76K | $ -77.42K | $ -50.28K |
| Financing Cash Flow | $ 3.43M | $ 500.02K | $ 722.10K | $ 1.55M | $ 702.05K |
Currency in GBP
